SUBSCRIBE
SUBSCRIBE
News   Business   Deals

Bristol-Myers Squibb Company Announces Completion of ConvaTec Divestiture

August 1, 2008 | 
1 min read
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that Nordic Capital Fund VII and Avista Capital Partners have completed their acquisition of ConvaTec, a business unit of Bristol-Myers Squibb.
Mergers & acquisitions
Bristol Myers Squibb Company
MORE ON THIS TOPIC
Police officer and sheriff, standing on the egde of the cliff. Handmade painting, acrylic on paper & post processing.
Earnings
Sanofi targets late-phase and commercial M&A to offset looming Dupixent decline
October 30, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Robotic claw clutching a money stock illustration
Drug Development
Dren Bio lands $350M to push rare blood cancer therapy toward market
October 29, 2026
 · 
2 min read
 · 
Gabrielle Masson
Hand shake icon on wooden cube block which connection with human icon for business deal and agreement concept.
Immuno-oncology
Astellas bets up to $1.34B for option to advance Audax immuno-oncology asset
October 28, 2026
 · 
2 min read
 · 
Tristan Manalac
Business growth or increase in professional income, business operations, investment profits or interest on savings, increase in interest rates, businessman holding gold coins forming a growing arrow symbol.
Earnings
Biogen notches 3rd straight quarter of growth thanks to newer products, Apellis
October 28, 2026
 · 
1 min read
 · 
Annalee Armstrong